Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
SMMT - NET INCOME
Net Income SMMT - Summit Therapeutics Inc.
-615 M
LAST VALUE
-163.45%
2 YEAR CAGR
-148.20%
5 YEAR CAGR
-49.46%
10 YEAR CAGR